Alembic Pharmaceuticals and Amlan International launch MinerTox-Z and MinerTox-A

Alembic Pharmaceuticals Ltd., through a strategic agreement with Amlan International, today announced the India launch of MinerTox-Z and MinerTox-A, feed additive solutions developed to protect poultry against toxins and enhance farm productivity.

The introduction of these products represents an important step in addressing one of the poultry industry’s most pressing challenges—losses caused by toxins. By combining Alembic’s strong presence in India with Amlan’s globally proven technology, this launch ensures that farmers gain access to advanced solutions designed specifically to safeguard flock health and profitability.

MinerTox-Z delivers broad-spectrum protection through rapid binding efficiency against both fungal (mycotoxins) and bacterial toxins, while MinerTox-A is an advanced mycotoxin binder engineered to provide long-lasting results. Together, they go beyond traditional toxin binding by strengthening immunity, protecting bird performance, and reducing hidden economic losses.

Highlighting the importance of this launch, Mr. P. Karunanithi, Executive Vice President (Cluster Head) of the Animal Health Division, Alembic Pharmaceuticals Ltd., said, "MinerTox-Z and MinerTox-A are more than just toxin binders; they represent a science-driven approach to empowering Indian poultry farmers. By helping protect birds from multiple threats and improving their overall resilience, these solutions will enable an immunity boost & ensure consistent productivity."

This launch reinforces the joint commitment of Alembic Pharmaceuticals and Amlan International to advancing poultry health with modern, sustainable, and performance-focused innovations.

About Alembic Pharmaceuticals Limited:

Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state-of-the-art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA. Alembic is one of the leaders in branded generics in India. Alembic's brands, marketed through a field force of over 5200 are well recognized by doctors and patients.